prednisone has been researched along with vorinostat in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Copeland, A; Fayad, LE; Fowler, N; Hagemeister, F; Kwak, LW; McLaughlin, P; Oki, Y; Pro, B; Romaguera, J; Shah, J; Younes, A | 1 |
| Anderson, KC; Attal, M; Holstein, SA; McCarthy, PL; Richardson, PG; Schlossman, RL | 1 |
| Bane, CL; Barr, PM; Fisher, RI; Friedberg, JW; LeBlanc, M; Li, H; Persky, DO; Popplewell, LL; Rimsza, LM; Smith, SM; Von Gehr, A | 1 |
| Aboulafia, D; Ambinder, RF; Baiocchi, R; Capoferri, AA; Cesarman, E; Chadburn, A; Durand, CM; Kaplan, L; Lee, JY; Mitsuyasu, R; Moore, PC; Noy, A; Ramos, JC; Ratner, L; Reid, EG; Rubinstein, PG; Siegel, ER; Sparano, JA | 1 |
| Gong, W; Hong, Y; Li, L; Liu, X; Meng, B; Meng, S; Qian, Z; Qiu, L; Ren, T; Ren, X; Wang, X; Zhai, Q; Zhang, H; Zhang, T; Zhao, M; Zhou, S | 1 |
2 review(s) available for prednisone and vorinostat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunologic Factors; Lenalidomide; Multiple Myeloma; Neutropenia; Prednisone; Thalidomide; Transplantation, Autologous; Vorinostat | 2017 |
3 trial(s) available for prednisone and vorinostat
| Article | Year |
|---|---|
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Hydroxamic Acids; Lymphoma, T-Cell, Peripheral; Prednisone; Treatment Outcome; Vincristine; Vorinostat | 2013 |
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytokines; Doxorubicin; Febrile Neutropenia; Female; Follow-Up Studies; Histone Deacetylase Inhibitors; HLA-D Antigens; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Progression-Free Survival; Rituximab; Sepsis; Treatment Outcome; Vincristine; Vorinostat; Young Adult | 2018 |
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; DNA, Viral; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Viral Load; Vorinostat | 2020 |
3 other study(ies) available for prednisone and vorinostat
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Cytokines; Doxorubicin; Epigenesis, Genetic; Histone Methyltransferases; Humans; Lymphoma, Large B-Cell, Diffuse; Myeloid Differentiation Factor 88; Prednisone; Prognosis; Protein Methyltransferases; Rituximab; Transcriptome; Vincristine; Vorinostat | 2022 |